Maxcyte shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Maxcyte
Tip: Access up to 7 years of quarterly data
All positions including Maxcyte held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Maxcyte by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $67k | 43k | 1.58 |
| 2025-06-30 | $131k | 60k | 2.18 |
| 2025-03-31 | $164k | 60k | 2.73 |
| 2024-12-31 | $254k | 61k | 4.16 |
| 2024-09-30 | $237k | 61k | 3.89 |
| 2024-06-30 | $239k | 61k | 3.92 |
| 2023-12-31 | $224k | 48k | 4.70 |
| 2023-09-30 | $149k | 48k | 3.12 |
| 2023-06-30 | $219k | 48k | 4.59 |
| 2023-03-31 | $278k | 56k | 4.95 |
| 2022-12-31 | $306k | 56k | 5.46 |
| 2022-09-30 | $365k | 56k | 6.50 |
| 2022-06-30 | $266k | 56k | 4.73 |
| 2022-03-31 | $392k | 56k | 6.99 |
| 2021-12-31 | $368k | 36k | 10.19 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors